
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
PI 3-kinase p100 CRISPR/Cas9 KO Plasmid (m) | sc-432531 | 20 µg | $397.00 |
Pik3c3 encodes the class III phosphatidylinositol 3-kinase catalytic subunit (often referred to as PI 3-kinase p100/Vps34), which generates phosphatidylinositol 3-phosphate to control endosomal membrane identity and trafficking. In mouse cells, PI3P production by this kinase is central to autophagy initiation, endosome-to-lysosome maturation, and vesicular sorting through complexes with regulatory partners such as VPS15 and Beclin 1. Pik3c3 activity integrates nutrient and stress cues to coordinate lysosomal homeostasis and cellular quality control, influencing processes including proteostasis, mitochondrial turnover, and immune signaling. Dysregulated endolysosomal and autophagy pathways linked to Pik3c3 function are frequently studied in the context of neurodegeneration, infection biology, and tumor cell metabolism.
PI 3-kinase p100 CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Pik3c3 gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Pik3c3 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Pik3c3 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish PI 3-kinase p100 protein expression.
This CRISPR knockout system enables efficient generation of Pik3c3-deficient cell models for investigation of PI 3-kinase p100 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.